BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 30811284)

  • 1. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.
    Merchant TE; Bendel AE; Sabin ND; Burger PC; Shaw DW; Chang E; Wu S; Zhou T; Eisenstat DD; Foreman NK; Fuller CE; Anderson ET; Hukin J; Lau CC; Pollack IF; Laningham FH; Lustig RH; Armstrong FD; Handler MH; Williams-Hughes C; Kessel S; Kocak M; Ellison DW; Ramaswamy V
    J Clin Oncol; 2019 Apr; 37(12):974-983. PubMed ID: 30811284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
    Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
    Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study.
    Merchant TE; Li C; Xiong X; Kun LE; Boop FA; Sanford RA
    Lancet Oncol; 2009 Mar; 10(3):258-66. PubMed ID: 19274783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Supratentorial Ependymoma: Surgical, Clinical, and Molecular Analysis.
    Lillard JC; Venable GT; Khan NR; Tatevossian RG; Dalton J; Vaughn BN; Klimo P
    Neurosurgery; 2019 Jul; 85(1):41-49. PubMed ID: 29917116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supratentorial ependymoma in children: to observe or to treat following gross total resection?
    Venkatramani R; Dhall G; Patel M; Grimm J; Hawkins C; McComb G; Krieger M; Wong K; O'Neil S; Finlay JL
    Pediatr Blood Cancer; 2012 Mar; 58(3):380-3. PubMed ID: 21370439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
    Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
    Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma.
    Merchant TE; Kiehna EN; Li C; Xiong X; Mulhern RK
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1546-54. PubMed ID: 16115736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma.
    Nakamura T; Fukuoka K; Ikeda J; Yoshitomi M; Udaka N; Tanoshima R; Tateishi K; Yamanaka S; Ichimura K; Yamamoto T
    Brain Tumor Pathol; 2017 Oct; 34(4):160-164. PubMed ID: 28831588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is gross-total resection sufficient treatment for posterior fossa ependymomas?
    Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T; Speiser B
    J Neurosurg; 2005 Apr; 102(4):629-36. PubMed ID: 15871504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
    Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
    J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ependymal tumors in childhood.
    Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
    Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratentorial ependymoma: disease control, complications, and functional outcomes after irradiation.
    Landau E; Boop FA; Conklin HM; Wu S; Xiong X; Merchant TE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):e193-9. PubMed ID: 23245280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma.
    Merchant TE; Mulhern RK; Krasin MJ; Kun LE; Williams T; Li C; Xiong X; Khan RB; Lustig RH; Boop FA; Sanford RA
    J Clin Oncol; 2004 Aug; 22(15):3156-62. PubMed ID: 15284268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues.
    Delgado-López PD; Corrales-García EM; Alonso-García E; García-Leal R; González-Rodrigálvarez R; Araus-Galdós E; Martín-Alonso J
    Clin Transl Oncol; 2019 Nov; 21(11):1450-1463. PubMed ID: 30868390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, radiological, and histological features and treatment outcomes of supratentorial extraventricular ependymoma: 14 cases from a single center.
    Sun S; Wang J; Zhu M; Beejadhursing R; Gao P; Zhang X; Jiao L; Jiang W; Ke C; Shu K
    J Neurosurg; 2018 May; 128(5):1396-1402. PubMed ID: 28686116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
    Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
    Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and Genetic Features of Supratentorial Cortical Ependymomas.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Date I
    World Neurosurg; 2019 Sep; 129():e417-e428. PubMed ID: 31150846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
    Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
    Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.